Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Phenylbutazone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 known ✓ | P23219 | 2/20 | 0.82 |
| ▸ | RAB9A | P51151 | 3/20 | 0.82 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.82 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.82 |
| ▸ | LMNA | P02545 | 2/20 | 0.82 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.82 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.82 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.82 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.82 |
| ▸ | TP53 | P04637 | 1/20 | 0.82 |
| ▸ | MAPT | P10636 | 1/20 | 0.82 |
| ▸ | HPGD | P15428 | 1/20 | 0.82 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.82 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.53 |
| ▸ | GRM2 | Q14416 | 5/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenylbutazone SCHEMBL3632 | 1.00 | RAB9A (0.82) | RAB9AALDH1A1CYP3A4LMNAPTGS1 | |
| Phenylbutazone SCHEMBL2122724 | 0.98 | RAB9A (0.80) | RAB9AALDH1A1CYP3A4LMNAPTGS1 | |
| Phenylbutazone SCHEMBL21694456 | 0.98 | RAB9A (0.80) | RAB9AALDH1A1CYP3A4LMNAPTGS1 | |
| Phenylbutazone SCHEMBL2874252 | 0.98 | RAB9A (0.80) | RAB9AALDH1A1CYP3A4LMNAPTGS1 | |
| Phenylbutazone SCHEMBL7715162 | 0.98 | RAB9A (0.80) | RAB9AALDH1A1CYP3A4LMNAPTGS1 | |
| Phenylbutazone SCHEMBL10913190 | 0.98 | RAB9A (0.80) | RAB9AALDH1A1CYP3A4LMNAPTGS1 | |
| SCHEMBL29489697 | 0.93 | ALDH1A1 (0.73) | RAB9AALDH1A1CYP3A4LMNAPTGS1 | |
| Phenylbutazone SCHEMBL11269971 | 0.92 | ALDH1A1 (0.72) | RAB9AALDH1A1CYP3A4LMNAPTGS1 | |
| Oxyphenbutazone Anhydrous SCHEMBL25857 | 0.91 | LMNA (1.00) | RAB9AALDH1A1CYP3A4LMNAPTGS1 | |
| Oxyphenbutazone Anhydrous SCHEMBL25856 | 0.91 | LMNA (1.00) | RAB9AALDH1A1CYP3A4LMNAPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2000022109-A1 | MOLECULAR MARKERS FOR DETERMINING A PATIENT'S RISK OF DEVELOPING AGRANULOCYTOSIS | MILLENNIUM PREDICTIVE MEDICINE, INC. (US) | 2000-04-20 | — | — | WO | disclosed |
| US-6022563-A | POWDERED CARRIER CONSISTING OF SWEETENERS, FLAVORING AGENTS, ANTI-CAKING AGENTS AND THERAPEUTICALLY EFFECTIVE AMOUNT OF PHENYLBUTAZONE FOR TREATMENT OF EQUINE AILMENTS COMPRISING JOINT DETERIORATION, SWELLING | SUPERIOR EQUINE PHARMACEUTICALS, INC. (US) | 2000-02-08 | — | — | US | disclosed |
| US-4883798-A | ANALGESIC, ANTIPYRETIC, ANTIINFLAMMATORY, ANTIANGINAL AND ANTIOXIDANT AGENT | EGIS GYOGYSZERGYAR (HU) | 1989-11-28 | — | — | US | disclosed |
| US-4873249-A | 2,4-DIAMINO-5-(3,4-DIMETHOXY-BENZYL)-PYRIMIDINE; ANALGESIC OR ANTINFLAMMATORY AGENT | EGIS GYOGYSZERGYAR (HU) | 1989-10-10 | — | — | US | disclosed |
| US-4292319-A | MIXTURE WITH AN ANTIULCER AGENT | BOEHRINGER INGELHEIM GMBH (DE) | 1981-09-29 | — | — | US | disclosed |
| US-4256747-A | ANTIINFLAMMATORY AGENTS, PYRIDO/2,3B//1,4/BENZODIAZEPIN-6-ONES | BOEHRINGER INGELHEIM GMBH (DE) | 1981-03-17 | — | — | US | disclosed |
| US-4154833-A | INDOMETHACIN (1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOLE-3-ACETIC ACID) WITH PIRENZEPINE (5,11-DIHYDRO-11-((4-METHYL-1-PIPERAZINYL)-ACETYL)-6H-PYRIDO(2,3 -B)(1,4)BENZODIAZEPIN-6-ONE) | BOEHRINGER INGELHEIM GMBH (DE) | 1979-05-15 | — | — | US | disclosed |
| US-4004002-A | PREVENT GASTRIC IRRITATION | A. H. ROBINS COMPANY, INCORPORATED (US) | 1977-01-18 | — | — | US | disclosed |